2161.HK HKSE
JBM (Healthcare) Limited
1W: -1.8%
1M: -11.0%
3M: -17.4%
YTD: -40.4%
1Y: -42.1%
3Y: +57.3%
5Y: +39.7%
HK$1.61 ($0.21)
-0.01 (-0.62%)
Weekly Expected Move ±2.6%
HK$2
HK$2
HK$2
HK$2
HK$2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$782M
+20.6% ▲
5Y CAGR: +15.4%
Gross Profit
$414M
+22.4% ▲
5Y CAGR: +16.8%
Operating Income
$246M
+41.2% ▲
5Y CAGR: +36.5%
Net Income
$197M
+51.2% ▲
5Y CAGR: +36.9%
EPS (Diluted)
$0.24
+60.0% ▲
5Y CAGR: +39.2%
EBITDA
$298M
+35.2% ▲
5Y CAGR: +26.9%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $397M | $406M | $520M | $648M | $782M |
| YoY Growth | +4.1% | +2.3% | +28.1% | +24.6% | +20.6% |
| Cost of Revenue | $216M | $264M | $332M | $310M | $369M |
| Gross Profit | $181M | $142M | $188M | $338M | $414M |
| Gross Margin | 45.6% | 35.0% | 36.1% | 52.1% | 52.9% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $160M | $125M | $138M | $180M | $186M |
| Operating Expenses | $110M | $106M | $120M | $164M | $168M |
| Operating Income | $71M | $36M | $68M | $174M | $246M |
| Operating Margin | 17.9% | 9.0% | 13.0% | 26.9% | 31.5% |
| Interest Expense | $7M | $6M | $8M | $8M | $4M |
| Income Before Tax | $43M | $33M | $79M | $165M | $242M |
| Tax Expense | $11M | $7M | $14M | $28M | $39M |
| Net Income | $23M | $25M | $57M | $130M | $197M |
| Net Margin | 5.7% | 6.1% | 11.0% | 20.1% | 25.2% |
| EPS (Diluted) | $0.03 | $0.03 | $0.06 | $0.15 | $0.24 |
| EBITDA | $115M | $84M | $111M | $221M | $298M |
| Shares Outstanding | 894M | 894M | 891M | 884M | 819M |